Relafen 750, recognized as naproxol, embodies a distinct example of selective biochemical action within the realm of inflammatory conditions. From a therapeutic perspective, its mechanism of activity copyrights upon the inhibition of cyclooxygenase (COX) proteins, particularly COX-2, involved in the production of inflammatory mediators . This targe